228 related articles for article (PubMed ID: 24034490)
1. Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: summary of an ecological study.
Miller PE; Rambachan A; Hubbard RJ; Li J; Meyer AE; Stephens P; Mounts AW; Rolfes MA; Penn CR
Influenza Other Respir Viruses; 2013 Sep; 7 Suppl 2(Suppl 2):82-86. PubMed ID: 24034490
[TBL] [Abstract][Full Text] [Related]
2. Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological study.
Miller PE; Rambachan A; Hubbard RJ; Li J; Meyer AE; Stephens P; Mounts AW; Rolfes MA; Penn CR
PLoS One; 2012; 7(9):e43491. PubMed ID: 22984431
[TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
[TBL] [Abstract][Full Text] [Related]
4. Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data.
Heneghan CJ; Onakpoya I; Jones MA; Doshi P; Del Mar CB; Hama R; Thompson MJ; Spencer EA; Mahtani KR; Nunan D; Howick J; Jefferson T
Health Technol Assess; 2016 May; 20(42):1-242. PubMed ID: 27246259
[TBL] [Abstract][Full Text] [Related]
5. Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic.
Dixit R; Khandaker G; Ilgoutz S; Rashid H; Booy R
Infect Disord Drug Targets; 2013 Feb; 13(1):34-45. PubMed ID: 23675925
[TBL] [Abstract][Full Text] [Related]
6. Systematic review of influenza resistance to the neuraminidase inhibitors.
Thorlund K; Awad T; Boivin G; Thabane L
BMC Infect Dis; 2011 May; 11():134. PubMed ID: 21592407
[TBL] [Abstract][Full Text] [Related]
7. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons.
Kawai N; Ikematsu H; Tanaka O; Matsuura S; Maeda T; Yamauchi S; Hirotsu N; Nishimura M; Iwaki N; Kashiwagi S
J Infect Chemother; 2011 Jun; 17(3):375-81. PubMed ID: 21120678
[TBL] [Abstract][Full Text] [Related]
9. [Influenza A, pregnancy and neuraminidase inhibitors].
Montané E; Lecumberri J; Pedro-Botet ML
Med Clin (Barc); 2011 May; 136(15):688-93. PubMed ID: 20416906
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.
Muthuri SG; Venkatesan S; Myles PR; Leonardi-Bee J; Al Khuwaitir TS; Al Mamun A; Anovadiya AP; Azziz-Baumgartner E; Báez C; Bassetti M; Beovic B; Bertisch B; Bonmarin I; Booy R; Borja-Aburto VH; Burgmann H; Cao B; Carratala J; Denholm JT; Dominguez SR; Duarte PA; Dubnov-Raz G; Echavarria M; Fanella S; Gao Z; Gérardin P; Giannella M; Gubbels S; Herberg J; Iglesias AL; Hoger PH; Hu X; Islam QT; Jiménez MF; Kandeel A; Keijzers G; Khalili H; Knight M; Kudo K; Kusznierz G; Kuzman I; Kwan AM; Amine IL; Langenegger E; Lankarani KB; Leo YS; Linko R; Liu P; Madanat F; Mayo-Montero E; McGeer A; Memish Z; Metan G; Mickiene A; Mikić D; Mohn KG; Moradi A; Nymadawa P; Oliva ME; Ozkan M; Parekh D; Paul M; Polack FP; Rath BA; Rodríguez AH; Sarrouf EB; Seale AC; Sertogullarindan B; Siqueira MM; Skręt-Magierło J; Stephan F; Talarek E; Tang JW; To KK; Torres A; Törün SH; Tran D; Uyeki TM; Van Zwol A; Vaudry W; Vidmar T; Yokota RT; Zarogoulidis P; ; Nguyen-Van-Tam JS
Lancet Respir Med; 2014 May; 2(5):395-404. PubMed ID: 24815805
[TBL] [Abstract][Full Text] [Related]
12. Influenza viruses resistant to neuraminidase inhibitors.
Nitsch-Osuch A; Brydak LB
Acta Biochim Pol; 2014; 61(3):505-8. PubMed ID: 25195142
[TBL] [Abstract][Full Text] [Related]
13. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
14. The use of antiviral agents for the management of severe influenza.
Smith JR; Ariano RE; Toovey S
Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416
[TBL] [Abstract][Full Text] [Related]
15. Neuraminidase inhibitors for critically ill children with influenza.
Louie JK; Yang S; Samuel MC; Uyeki TM; Schechter R
Pediatrics; 2013 Dec; 132(6):e1539-45. PubMed ID: 24276847
[TBL] [Abstract][Full Text] [Related]
16. Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.
Okomo-Adhiambo M; Sleeman K; Lysén C; Nguyen HT; Xu X; Li Y; Klimov AI; Gubareva LV
Influenza Other Respir Viruses; 2013 Sep; 7(5):645-58. PubMed ID: 23575174
[TBL] [Abstract][Full Text] [Related]
17. Administration of neuraminidase inhibitors for the treatment of Japanese patients infected with the novel influenza A (H1N1).
Ohnishi K; Nakamura-Uchiyama F
J Infect Chemother; 2010 Feb; 16(1):62-3. PubMed ID: 20072797
[TBL] [Abstract][Full Text] [Related]
18. Oseltamivir-resistant pandemic (H1N1) 2009 virus, Mexico.
Ramirez-Gonzalez JE; Gonzalez-Duran E; Alcantara-Perez P; Wong-Arambula C; Olivera-Diaz H; Cortez-Ortiz I; Barrera-Badillo G; Nguyen H; Gubareva L; Lopez-Martinez I; Díaz-Quiñonez JA; Lezana-Fernández MA; Gatell-Ramírez HL; Cordova Villalobos JA; Hernández-Avila M; Alpuche-Aranda C
Emerg Infect Dis; 2011 Feb; 17(2):283-6. PubMed ID: 21291607
[TBL] [Abstract][Full Text] [Related]
19. Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B.
Kawai N; Ikematsu H; Kawashima T; Maeda T; Ukai H; Hirotsu N; Iwaki N; Kashiwagi S
Influenza Other Respir Viruses; 2013 May; 7(3):448-55. PubMed ID: 22897904
[TBL] [Abstract][Full Text] [Related]
20. Treatment of influenza with neuraminidase inhibitors.
Beard KR; Brendish NJ; Clark TW
Curr Opin Infect Dis; 2018 Dec; 31(6):514-519. PubMed ID: 30320639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
